AI Impact on Liquid Biopsy with Emphasis on Cancer Market - BCC Pulse Report

September 2026 | 12 pages | ID: A161320B78E2EN
BCC Research

Abstracts

This report covers the AI impact on the liquid biopsy market. It highlights key use cases for AI in cancer detection, diagnosis, patient stratification, monitoring, and treatment planning, along with adoption trends across different geographic regions. It also examines how AI is reshaping cancer care and creating new opportunities for companies in the liquid biopsy market.

Report Scope

AI is reshaping the global liquid biopsy market, particularly in cancer applications, by improving biomarker detection, ctDNA analysis, and early cancer diagnosis. Its use is expanding across precision oncology, disease monitoring, clinical decision-making, and workflow optimization, while also influencing the liquid biopsy value chain, industry adoption, and investment priorities.

Report Includes

• Impact analysis of artificial intelligence (AI) on the global liquid biopsy market, with a focus on cancer applications
• Case studies for successful integration of AI and machine learning in biomarker detection, circulating tumor DNA (ctDNA) analysis, early cancer diagnosis and disease monitoring
• Highlights of AI adoption trends across major geographical regions, as well as disruptions caused by AI across key oncology, diagnostics and biotechnology industry verticals
• AI’s role in precision oncology, test development, clinical decision-making and workflow optimization
• Review of AI impact on the various stages of the global liquid biopsy value chain and supply chain analysis
• Competitive landscape featuring key strategic initiatives, market spendings and an investment outlook

Contents

CHAPTER 1 KEY USE CASES FOR AI ADOPTION IN LIQUID BIOPSY WITH EMPHASIS ON CANCER

Overview
Key Use Cases/Case Studies
Case 1: Next-Generation Sequencing (NGS)
Case 2: Polymerase Chain Reaction (PCR)
Case 3: Other Technologies

CHAPTER 2 AI ADOPTION TRENDS

Adoption Trends by Region
Adoption Trends in North America
Adoption Trends in Europe
Adoption Trends in Asia-Pacific
Adoption Trends in the Rest of the World

CHAPTER 3 AI DISRUPTION TRENDS

Impact of AI on Key Industry Verticals
Therapy Monitoring
Recurrence Monitoring
Therapy Guidance
Early Cancer Screening
Impact of AI on Various Stages of the Supply Chain
Biomarker Discovery and Assay Development
Sample Processing and Data Generation
Data Analysis and Clinical Interpretation
Clinical Application and Commercial Deployment

CHAPTER 4 MARKET SPENDING AND INVESTMENT SCENARIO

Overview
Market Spending and Forecasting Analysis
Key Spending by Technologies for Liquid Biopsy with Emphasis on Cancer on AI
Venture Capital Investment in AI for Liquid Biopsy with Emphasis on Cancer
Notable Venture Capital Investments

CHAPTER 5 ABBREVIATIONS

Abbreviations Used in the Report

List Of Tables

LIST OF TABLES
Table 1 : Key Initiatives by Companies on AI, 2025-2026
Table 2 : Key Spending by Companies on AI-based Liquid Biopsy, 2023-2026
Table 3 : Abbreviations Used in This Report

List Of Figures

LIST OF FIGURES
Figure 1 : Impact of AI on Value Chain